Clinical stage biotech Prescient Therapeutics is developing new therapies for cancers of unmet need, including cutaneous ...

June brought major blood cancer updates, and CURE is sharing the latest in myelofibrosis treatment and FDA breakthroughs, as ...

CURE connects oncology patients, survivors, and caregivers with expert guidance, cancer updates, treatment education, and ...

Advocates for veterans are championing Assembly Bill 1103, which would fast-track the approval of academic studies on ...

Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) is one of the best biotech stocks to invest in now. On June 3, Amylyx ...

In announcing his new Commissioner's National Priority Voucher (CNPV) program, FDA Commissioner Marty Makary, MD, MPH, ...

Healthy volunteers were given either ISLA-101 or a placebo, then deliberately exposed to a weakened strain of dengue virus.

FNP-223 is currently being investigated in a phase 2 trial evaluating the treatment in adults with possible or probable PSP-Richardson syndrome.

The FDA announced a new national priority voucher plan that aims to cut drug review times, while Headspace launches direct-to ...